TY  - GEN
AU  - Hanai,Jun-ichi
AU  - Doro,Nathaniel
AU  - Sasaki,Atsuo T
AU  - Kobayashi,Susumu
AU  - Cantley,Lewis C
AU  - Seth,Pankaj
AU  - Sukhatme,Vikas P
TI  - Inhibition of lung cancer growth: ATP citrate lyase knockdown and statin treatment leads to dual blockade of mitogen-activated protein kinase (MAPK) and phosphatidylinositol-3-kinase (PI3K)/AKT pathways
SN  - 1097-4652
PY  - 2012///0305
KW  - ATP Citrate (pro-S)-Lyase
KW  - antagonists & inhibitors
KW  - Animals
KW  - Apoptosis
KW  - Cell Cycle
KW  - Cell Line, Tumor
KW  - Cell Proliferation
KW  - Combined Modality Therapy
KW  - Epithelial-Mesenchymal Transition
KW  - ErbB Receptors
KW  - genetics
KW  - Female
KW  - Gene Knockdown Techniques
KW  - Humans
KW  - Hydroxymethylglutaryl-CoA Reductase Inhibitors
KW  - therapeutic use
KW  - Lung Neoplasms
KW  - drug therapy
KW  - MAP Kinase Signaling System
KW  - drug effects
KW  - Mice
KW  - Mutation
KW  - Phosphoinositide-3 Kinase Inhibitors
KW  - Proto-Oncogene Proteins c-akt
KW  - Signal Transduction
KW  - Xenograft Model Antitumor Assays
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1002/jcp.22895
ER  -